Spots Global Cancer Trial Database for patients with malignant solid tumors of any histologically confirmed, not susceptible of cure, which have received the standard treatment available
Every month we try and update this database with for patients with malignant solid tumors of any histologically confirmed, not susceptible of cure, which have received the standard treatment available cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors | NCT01548924 | Solid Tumors | Dovitinib Dovitinib + Pac... | 18 Years - 76 Years | Centro Nacional de Investigaciones Oncologicas CARLOS III |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
